| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Transesophageal | 57 | 2021 | 1133 | 5.920 |
Why?
|
| Mitral Valve | 17 | 2020 | 1491 | 3.110 |
Why?
|
| Echocardiography, Three-Dimensional | 15 | 2020 | 591 | 3.070 |
Why?
|
| Mitral Valve Insufficiency | 16 | 2021 | 1422 | 2.520 |
Why?
|
| Coronary Artery Bypass | 48 | 2021 | 2289 | 2.180 |
Why?
|
| Cardiac Surgical Procedures | 38 | 2023 | 3537 | 2.070 |
Why?
|
| Mitral Valve Stenosis | 7 | 2018 | 376 | 1.830 |
Why?
|
| Monitoring, Intraoperative | 19 | 2019 | 957 | 1.660 |
Why?
|
| Echocardiography, Doppler, Color | 6 | 2019 | 364 | 1.300 |
Why?
|
| Ventricular Outflow Obstruction | 4 | 2016 | 272 | 1.020 |
Why?
|
| Echocardiography | 17 | 2021 | 5102 | 1.000 |
Why?
|
| Perioperative Care | 12 | 2016 | 1002 | 0.900 |
Why?
|
| Heart Valve Prosthesis Implantation | 9 | 2021 | 1536 | 0.830 |
Why?
|
| Anesthesiology | 7 | 2023 | 1060 | 0.740 |
Why?
|
| Cardiopulmonary Bypass | 18 | 2019 | 1066 | 0.740 |
Why?
|
| Myocardial Ischemia | 9 | 2021 | 2148 | 0.720 |
Why?
|
| Complement C5 | 7 | 2010 | 112 | 0.720 |
Why?
|
| Intra-Aortic Balloon Pumping | 5 | 2015 | 219 | 0.660 |
Why?
|
| Echocardiography, Doppler | 7 | 2014 | 935 | 0.650 |
Why?
|
| Cardiology | 9 | 2023 | 1668 | 0.640 |
Why?
|
| Intraoperative Complications | 13 | 2010 | 1198 | 0.600 |
Why?
|
| Intraoperative Care | 9 | 2010 | 767 | 0.560 |
Why?
|
| Complement Activation | 5 | 2012 | 453 | 0.520 |
Why?
|
| Pericardium | 6 | 2017 | 667 | 0.480 |
Why?
|
| Hemodynamics | 7 | 2019 | 4199 | 0.480 |
Why?
|
| Anesthesia | 3 | 2023 | 1561 | 0.480 |
Why?
|
| Diastole | 2 | 2015 | 791 | 0.450 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2014 | 143 | 0.440 |
Why?
|
| Postoperative Complications | 35 | 2017 | 15295 | 0.440 |
Why?
|
| Heart Diseases | 6 | 2017 | 2788 | 0.420 |
Why?
|
| Myocardial Reperfusion Injury | 4 | 2006 | 476 | 0.420 |
Why?
|
| Heart Valves | 5 | 2017 | 291 | 0.400 |
Why?
|
| Tricuspid Valve Insufficiency | 4 | 2023 | 349 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2010 | 535 | 0.390 |
Why?
|
| Heart Valve Diseases | 7 | 2017 | 1073 | 0.370 |
Why?
|
| Heart Aneurysm | 1 | 2010 | 120 | 0.370 |
Why?
|
| Suture Techniques | 1 | 2014 | 798 | 0.350 |
Why?
|
| Predictive Value of Tests | 21 | 2019 | 15076 | 0.340 |
Why?
|
| Ventricular Function, Left | 6 | 2019 | 3670 | 0.340 |
Why?
|
| Ultrasonography, Interventional | 6 | 2009 | 1486 | 0.340 |
Why?
|
| Embolectomy | 6 | 2006 | 120 | 0.330 |
Why?
|
| Pulmonary Embolism | 12 | 2013 | 2376 | 0.330 |
Why?
|
| Heart Ventricles | 8 | 2017 | 3821 | 0.310 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2017 | 3327 | 0.300 |
Why?
|
| Single-Chain Antibodies | 10 | 2010 | 108 | 0.300 |
Why?
|
| Humans | 159 | 2023 | 744343 | 0.300 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2006 | 19 | 0.280 |
Why?
|
| Myocardial Infarction | 16 | 2010 | 11727 | 0.280 |
Why?
|
| Creatine Kinase, MB Form | 6 | 2010 | 214 | 0.280 |
Why?
|
| Sinus of Valsalva | 1 | 2006 | 59 | 0.270 |
Why?
|
| Myxoma | 1 | 2006 | 130 | 0.270 |
Why?
|
| Societies, Medical | 10 | 2023 | 3743 | 0.270 |
Why?
|
| Vena Cava, Superior | 1 | 2006 | 193 | 0.270 |
Why?
|
| Sternum | 1 | 2006 | 177 | 0.260 |
Why?
|
| Atrial Fibrillation | 9 | 2019 | 5034 | 0.260 |
Why?
|
| Natriuretic Peptide, Brain | 5 | 2013 | 1573 | 0.260 |
Why?
|
| Renal Replacement Therapy | 1 | 2007 | 257 | 0.260 |
Why?
|
| Pulmonary Artery | 5 | 2019 | 1912 | 0.250 |
Why?
|
| Antibodies, Monoclonal | 10 | 2010 | 9274 | 0.250 |
Why?
|
| Atrial Appendage | 1 | 2009 | 283 | 0.250 |
Why?
|
| Aorta | 5 | 2017 | 2061 | 0.250 |
Why?
|
| Ventricular Dysfunction | 3 | 2011 | 143 | 0.250 |
Why?
|
| Genetic Variation | 6 | 2014 | 6544 | 0.250 |
Why?
|
| Aortic Aneurysm | 2 | 2006 | 643 | 0.240 |
Why?
|
| Models, Cardiovascular | 4 | 2015 | 996 | 0.240 |
Why?
|
| Middle Aged | 70 | 2021 | 213383 | 0.240 |
Why?
|
| Male | 86 | 2021 | 350118 | 0.240 |
Why?
|
| Ventricular Dysfunction, Left | 7 | 2019 | 2073 | 0.240 |
Why?
|
| Heart Atria | 5 | 2017 | 1357 | 0.240 |
Why?
|
| Aged | 67 | 2021 | 163280 | 0.240 |
Why?
|
| Heart Transplantation | 5 | 2004 | 3110 | 0.230 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2006 | 549 | 0.220 |
Why?
|
| Heart Neoplasms | 1 | 2006 | 374 | 0.220 |
Why?
|
| Cardiac Output, Low | 1 | 2003 | 195 | 0.220 |
Why?
|
| American Heart Association | 4 | 2023 | 1056 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 11 | 2017 | 15519 | 0.210 |
Why?
|
| Female | 81 | 2020 | 380194 | 0.210 |
Why?
|
| Aged, 80 and over | 29 | 2017 | 57776 | 0.210 |
Why?
|
| Catheterization, Central Venous | 1 | 2006 | 514 | 0.200 |
Why?
|
| Anaphylatoxins | 1 | 2001 | 21 | 0.200 |
Why?
|
| Aortic Valve | 8 | 2017 | 1922 | 0.200 |
Why?
|
| Retrospective Studies | 23 | 2023 | 77449 | 0.190 |
Why?
|
| Reproducibility of Results | 10 | 2016 | 19905 | 0.190 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 1018 | 0.190 |
Why?
|
| Coronary Artery Disease | 6 | 2017 | 6487 | 0.180 |
Why?
|
| Coronary Disease | 5 | 2006 | 6077 | 0.180 |
Why?
|
| Coronary Vessels | 6 | 2023 | 3107 | 0.180 |
Why?
|
| Complement Membrane Attack Complex | 1 | 1999 | 112 | 0.180 |
Why?
|
| Polypropylenes | 1 | 1999 | 64 | 0.180 |
Why?
|
| Troponin I | 5 | 2010 | 619 | 0.180 |
Why?
|
| Antithrombin III | 2 | 2010 | 128 | 0.180 |
Why?
|
| Treatment Outcome | 27 | 2023 | 63114 | 0.170 |
Why?
|
| Reoperation | 3 | 2018 | 4201 | 0.170 |
Why?
|
| Heart | 5 | 2023 | 4467 | 0.170 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 581 | 0.170 |
Why?
|
| Stroke Volume | 2 | 2012 | 5007 | 0.160 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2003 | 488 | 0.160 |
Why?
|
| Membranes, Artificial | 1 | 1999 | 378 | 0.160 |
Why?
|
| Ventricular Function, Right | 3 | 2019 | 591 | 0.150 |
Why?
|
| Heart Failure | 7 | 2019 | 10900 | 0.150 |
Why?
|
| Heart Valve Prosthesis | 4 | 2021 | 1488 | 0.150 |
Why?
|
| Heart Arrest, Induced | 2 | 2015 | 355 | 0.150 |
Why?
|
| Perioperative Period | 3 | 2013 | 256 | 0.150 |
Why?
|
| Nitroglycerin | 1 | 1998 | 325 | 0.150 |
Why?
|
| Thrombosis | 2 | 2009 | 2968 | 0.150 |
Why?
|
| Aortic Diseases | 2 | 2017 | 742 | 0.150 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2006 | 1265 | 0.150 |
Why?
|
| Cardiovascular Surgical Procedures | 3 | 2007 | 194 | 0.140 |
Why?
|
| Heart-Assist Devices | 5 | 2019 | 1194 | 0.140 |
Why?
|
| Creatine Kinase | 3 | 2005 | 694 | 0.140 |
Why?
|
| Acute Kidney Injury | 4 | 2016 | 1972 | 0.140 |
Why?
|
| Materials Testing | 1 | 1999 | 867 | 0.140 |
Why?
|
| Anesthetics | 3 | 2014 | 539 | 0.140 |
Why?
|
| Nitric Oxide | 3 | 1999 | 2132 | 0.130 |
Why?
|
| Total Quality Management | 2 | 2006 | 274 | 0.130 |
Why?
|
| Capillaries | 1 | 1998 | 773 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 513 | 0.130 |
Why?
|
| Ventricular Remodeling | 1 | 2002 | 1224 | 0.120 |
Why?
|
| Haplotypes | 2 | 2014 | 2779 | 0.120 |
Why?
|
| Forecasting | 3 | 2016 | 2951 | 0.120 |
Why?
|
| Prospective Studies | 22 | 2017 | 53288 | 0.120 |
Why?
|
| Thoracic Surgery | 2 | 2013 | 719 | 0.120 |
Why?
|
| Alleles | 3 | 2016 | 6933 | 0.120 |
Why?
|
| Isoenzymes | 3 | 2005 | 1726 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 1998 | 977 | 0.120 |
Why?
|
| Severity of Illness Index | 8 | 2023 | 15540 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2019 | 642 | 0.120 |
Why?
|
| Pressure | 3 | 2014 | 1203 | 0.120 |
Why?
|
| Heme Oxygenase-1 | 1 | 2016 | 381 | 0.120 |
Why?
|
| Preoperative Period | 3 | 2010 | 549 | 0.110 |
Why?
|
| Aortic Valve Stenosis | 4 | 2014 | 1965 | 0.110 |
Why?
|
| Catheterization | 1 | 1998 | 1470 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 7279 | 0.110 |
Why?
|
| Cardiovascular Diseases | 5 | 2015 | 15165 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2018 | 2618 | 0.110 |
Why?
|
| Risk Assessment | 11 | 2017 | 23338 | 0.110 |
Why?
|
| Proportional Hazards Models | 10 | 2023 | 12354 | 0.110 |
Why?
|
| Aorta, Thoracic | 2 | 2012 | 1082 | 0.110 |
Why?
|
| Heparin | 2 | 2010 | 1637 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 713 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2014 | 199 | 0.100 |
Why?
|
| Postoperative Period | 6 | 2017 | 1842 | 0.100 |
Why?
|
| Bioprosthesis | 1 | 2016 | 596 | 0.100 |
Why?
|
| Risk Factors | 20 | 2019 | 72290 | 0.100 |
Why?
|
| Blood Pressure | 3 | 2013 | 8554 | 0.100 |
Why?
|
| Electrodes | 1 | 2014 | 619 | 0.100 |
Why?
|
| Receptors, Thrombin | 1 | 2012 | 131 | 0.100 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 1072 | 0.100 |
Why?
|
| Data Display | 1 | 2012 | 182 | 0.100 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 12959 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 725 | 0.100 |
Why?
|
| Profilins | 1 | 2010 | 66 | 0.090 |
Why?
|
| Indicator Dilution Techniques | 1 | 2010 | 40 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 2012 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 964 | 0.090 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2015 | 500 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 12072 | 0.090 |
Why?
|
| Adult | 30 | 2019 | 214055 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2016 | 1534 | 0.090 |
Why?
|
| Cardiovascular Agents | 2 | 2016 | 850 | 0.090 |
Why?
|
| Heart Injuries | 1 | 2012 | 210 | 0.090 |
Why?
|
| Genotype | 6 | 2016 | 12951 | 0.090 |
Why?
|
| Heart-Lung Machine | 2 | 2010 | 43 | 0.090 |
Why?
|
| United States | 17 | 2023 | 69872 | 0.090 |
Why?
|
| Lipocalins | 1 | 2010 | 170 | 0.090 |
Why?
|
| Intraoperative Period | 3 | 2013 | 520 | 0.080 |
Why?
|
| Time Factors | 14 | 2019 | 40075 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2017 | 2019 | 0.080 |
Why?
|
| Shock | 2 | 2006 | 318 | 0.080 |
Why?
|
| Length of Stay | 7 | 2010 | 6309 | 0.080 |
Why?
|
| Thromboembolism | 2 | 2006 | 986 | 0.080 |
Why?
|
| Device Removal | 1 | 2014 | 656 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1999 | 1354 | 0.080 |
Why?
|
| Polymorphism, Genetic | 3 | 2016 | 4328 | 0.080 |
Why?
|
| Clinical Competence | 5 | 2023 | 4687 | 0.080 |
Why?
|
| Chordae Tendineae | 1 | 2008 | 44 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2009 | 374 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1240 | 0.080 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2010 | 300 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2016 | 2740 | 0.080 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2011 | 478 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2010 | 1790 | 0.080 |
Why?
|
| Catheterization, Swan-Ganz | 2 | 2010 | 86 | 0.080 |
Why?
|
| C-Reactive Protein | 2 | 2010 | 3778 | 0.080 |
Why?
|
| Preoperative Care | 4 | 2010 | 2250 | 0.080 |
Why?
|
| Complement C3-C5 Convertases | 1 | 2007 | 37 | 0.080 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2007 | 21 | 0.080 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 1 | 2007 | 29 | 0.080 |
Why?
|
| Cardiac Output | 1 | 2010 | 854 | 0.070 |
Why?
|
| Heart Septum | 1 | 2008 | 313 | 0.070 |
Why?
|
| Double-Blind Method | 9 | 2010 | 12026 | 0.070 |
Why?
|
| Mannose-Binding Lectins | 1 | 2007 | 100 | 0.070 |
Why?
|
| Troponin | 1 | 2010 | 524 | 0.070 |
Why?
|
| Sufentanil | 1 | 2006 | 40 | 0.070 |
Why?
|
| Mannose-Binding Lectin | 1 | 2007 | 150 | 0.070 |
Why?
|
| Ischemia | 1 | 2015 | 1907 | 0.070 |
Why?
|
| Infusions, Intravenous | 3 | 2010 | 2274 | 0.070 |
Why?
|
| Injections, Intravenous | 3 | 2005 | 1420 | 0.070 |
Why?
|
| Hypotension | 3 | 2015 | 884 | 0.070 |
Why?
|
| Sutures | 1 | 2008 | 299 | 0.070 |
Why?
|
| Complement Inactivating Agents | 1 | 2006 | 50 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 1519 | 0.070 |
Why?
|
| Fistula | 1 | 2007 | 220 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 1997 | 0.060 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2009 | 579 | 0.060 |
Why?
|
| Image Enhancement | 2 | 2007 | 2921 | 0.060 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 550 | 0.060 |
Why?
|
| Europe | 4 | 2012 | 3339 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 1504 | 0.060 |
Why?
|
| Immunoassay | 1 | 2007 | 752 | 0.060 |
Why?
|
| Cardiomyopathies | 2 | 2010 | 1912 | 0.060 |
Why?
|
| Postoperative Hemorrhage | 2 | 2005 | 413 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2015 | 9849 | 0.060 |
Why?
|
| Atherosclerosis | 2 | 2010 | 3445 | 0.060 |
Why?
|
| Logistic Models | 4 | 2015 | 13408 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2017 | 6538 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2010 | 1167 | 0.060 |
Why?
|
| Follow-Up Studies | 11 | 2017 | 39050 | 0.060 |
Why?
|
| Decision Making | 2 | 2014 | 3887 | 0.060 |
Why?
|
| Embolism, Air | 2 | 2013 | 111 | 0.050 |
Why?
|
| Survival Analysis | 7 | 2013 | 10252 | 0.050 |
Why?
|
| Cytokines | 1 | 2017 | 7322 | 0.050 |
Why?
|
| Vena Cava Filters | 1 | 2005 | 252 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1738 | 0.050 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 935 | 0.050 |
Why?
|
| Acidosis | 1 | 2004 | 270 | 0.050 |
Why?
|
| Sensitivity and Specificity | 5 | 2008 | 14722 | 0.050 |
Why?
|
| Hospital Mortality | 3 | 2012 | 5317 | 0.050 |
Why?
|
| Myocardium | 1 | 2015 | 4776 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 2418 | 0.050 |
Why?
|
| Heart Arrest | 2 | 2015 | 1470 | 0.050 |
Why?
|
| Physical Examination | 1 | 2007 | 1237 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 3255 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2004 | 936 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2012 | 2508 | 0.050 |
Why?
|
| Coronary Circulation | 3 | 2010 | 1572 | 0.050 |
Why?
|
| Texas | 2 | 2013 | 392 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2219 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2005 | 675 | 0.050 |
Why?
|
| Health Resources | 1 | 2007 | 911 | 0.050 |
Why?
|
| Hospital Costs | 1 | 2007 | 985 | 0.050 |
Why?
|
| Cardiotonic Agents | 3 | 2010 | 535 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 2005 | 688 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 2046 | 0.050 |
Why?
|
| Electrocardiography | 3 | 2014 | 6442 | 0.040 |
Why?
|
| Longitudinal Studies | 6 | 2014 | 13989 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 17446 | 0.040 |
Why?
|
| Survival Rate | 5 | 2014 | 12788 | 0.040 |
Why?
|
| Cohort Studies | 9 | 2014 | 40561 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2004 | 680 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2011 | 1876 | 0.040 |
Why?
|
| Cattle | 2 | 2009 | 3922 | 0.040 |
Why?
|
| Embolism | 1 | 2002 | 408 | 0.040 |
Why?
|
| Platelet Adhesiveness | 1 | 1999 | 161 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 1917 | 0.040 |
Why?
|
| Respiration | 1 | 2006 | 1653 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3752 | 0.040 |
Why?
|
| Central Venous Pressure | 1 | 2019 | 78 | 0.040 |
Why?
|
| Aortography | 1 | 2001 | 437 | 0.040 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1999 | 134 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2006 | 1171 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 1999 | 383 | 0.040 |
Why?
|
| Heart Defects, Congenital | 3 | 2013 | 4584 | 0.040 |
Why?
|
| Consensus | 2 | 2021 | 2959 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2015 | 1654 | 0.040 |
Why?
|
| Endocarditis | 1 | 2002 | 350 | 0.040 |
Why?
|
| Analgesics | 1 | 2005 | 1040 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 941 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2019 | 332 | 0.040 |
Why?
|
| Piperidines | 1 | 2006 | 1602 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4554 | 0.040 |
Why?
|
| Psychological Tests | 1 | 1999 | 651 | 0.040 |
Why?
|
| Physicians | 1 | 2015 | 4567 | 0.040 |
Why?
|
| Critical Care | 1 | 2010 | 2647 | 0.040 |
Why?
|
| Equipment Failure | 2 | 2014 | 578 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1580 | 0.040 |
Why?
|
| Hemostasis | 1 | 2019 | 458 | 0.040 |
Why?
|
| Peer Review, Health Care | 2 | 2006 | 75 | 0.030 |
Why?
|
| Blood Circulation | 1 | 1997 | 251 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 434 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 2017 | 409 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 1999 | 662 | 0.030 |
Why?
|
| Swine | 2 | 2009 | 5917 | 0.030 |
Why?
|
| Ventricular Function | 1 | 1997 | 416 | 0.030 |
Why?
|
| Prognosis | 4 | 2023 | 29063 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 1999 | 1150 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2011 | 12261 | 0.030 |
Why?
|
| Adipokines | 1 | 2017 | 319 | 0.030 |
Why?
|
| China | 1 | 2021 | 2248 | 0.030 |
Why?
|
| ROC Curve | 2 | 2015 | 3527 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 235 | 0.030 |
Why?
|
| Blood Proteins | 1 | 1999 | 1124 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 1998 | 924 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 3597 | 0.030 |
Why?
|
| Protein Binding | 2 | 2012 | 9386 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2017 | 1137 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2017 | 6365 | 0.030 |
Why?
|
| Hospitalization | 1 | 2013 | 10262 | 0.030 |
Why?
|
| Genomics | 2 | 2011 | 5720 | 0.030 |
Why?
|
| Chromogranins | 1 | 2014 | 160 | 0.030 |
Why?
|
| Regression Analysis | 3 | 2010 | 6459 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1999 | 3144 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 2 | 2013 | 2212 | 0.030 |
Why?
|
| Stroke | 3 | 2017 | 9981 | 0.030 |
Why?
|
| Dual Specificity Phosphatase 2 | 1 | 2012 | 6 | 0.030 |
Why?
|
| Counterpulsation | 1 | 2012 | 19 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2010 | 2971 | 0.030 |
Why?
|
| Animals | 8 | 2016 | 168757 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1996 | 977 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 3508 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 1996 | 841 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2017 | 7729 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2017 | 1159 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2015 | 772 | 0.020 |
Why?
|
| Leukocytes | 1 | 1999 | 2043 | 0.020 |
Why?
|
| Education, Medical, Continuing | 2 | 2006 | 840 | 0.020 |
Why?
|
| Pericardial Effusion | 1 | 2013 | 247 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 2010 | 158 | 0.020 |
Why?
|
| Acute Disease | 2 | 2015 | 7149 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2019 | 1062 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2011 | 199 | 0.020 |
Why?
|
| Systole | 1 | 2013 | 958 | 0.020 |
Why?
|
| Thoracic Injuries | 1 | 2013 | 272 | 0.020 |
Why?
|
| Esophageal Perforation | 1 | 2010 | 69 | 0.020 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2010 | 30 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 2010 | 193 | 0.020 |
Why?
|
| Myoglobin | 1 | 2010 | 160 | 0.020 |
Why?
|
| Lithium Chloride | 1 | 2010 | 87 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 9438 | 0.020 |
Why?
|
| Coronary Stenosis | 2 | 2008 | 834 | 0.020 |
Why?
|
| Hypertension | 1 | 2010 | 8480 | 0.020 |
Why?
|
| Equipment Design | 2 | 2008 | 3582 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2006 | 3674 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1781 | 0.020 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2009 | 54 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2006 | 9959 | 0.020 |
Why?
|
| Clinical Enzyme Tests | 1 | 2009 | 115 | 0.020 |
Why?
|
| P-Selectin | 1 | 2012 | 600 | 0.020 |
Why?
|
| Acute-Phase Reaction | 1 | 2009 | 91 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2010 | 462 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1996 | 1072 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1991 | 705 | 0.020 |
Why?
|
| Platelet Count | 1 | 2012 | 781 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2010 | 262 | 0.020 |
Why?
|
| Emergencies | 2 | 2006 | 1170 | 0.020 |
Why?
|
| Boston | 2 | 2013 | 9313 | 0.020 |
Why?
|
| Hemoglobinuria | 1 | 2008 | 13 | 0.020 |
Why?
|
| Registries | 2 | 2015 | 8089 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2009 | 5078 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2008 | 103 | 0.020 |
Why?
|
| Young Adult | 5 | 2015 | 56430 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2012 | 673 | 0.020 |
Why?
|
| Oxygen | 1 | 1999 | 4189 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2012 | 669 | 0.020 |
Why?
|
| Linear Models | 2 | 2009 | 5952 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2009 | 393 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2015 | 3588 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2019 | 3461 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 2703 | 0.020 |
Why?
|
| Signal Transduction | 4 | 2017 | 23403 | 0.020 |
Why?
|
| Papillary Muscles | 1 | 2008 | 203 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2008 | 233 | 0.020 |
Why?
|
| Laboratories | 1 | 2011 | 463 | 0.020 |
Why?
|
| Pulmonary Circulation | 1 | 2010 | 739 | 0.020 |
Why?
|
| Cause of Death | 1 | 2017 | 3584 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 1785 | 0.020 |
Why?
|
| North America | 1 | 2010 | 1249 | 0.020 |
Why?
|
| Computer Systems | 1 | 2008 | 483 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2015 | 980 | 0.020 |
Why?
|
| Transducers | 1 | 2008 | 252 | 0.020 |
Why?
|
| Constriction | 1 | 2006 | 181 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1708 | 0.020 |
Why?
|
| Life Tables | 1 | 2006 | 370 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2012 | 1189 | 0.020 |
Why?
|
| Hemolysis | 1 | 2008 | 420 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 2892 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 868 | 0.020 |
Why?
|
| Premedication | 1 | 2006 | 258 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3279 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 1999 | 4043 | 0.020 |
Why?
|
| Genes | 1 | 2009 | 1893 | 0.020 |
Why?
|
| Pulmonary Atelectasis | 1 | 2006 | 145 | 0.020 |
Why?
|
| Sick Sinus Syndrome | 1 | 2004 | 44 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6756 | 0.020 |
Why?
|
| Safety Management | 1 | 2010 | 783 | 0.020 |
Why?
|
| Blood | 1 | 2007 | 598 | 0.020 |
Why?
|
| Age Factors | 2 | 2016 | 18370 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 1919 | 0.020 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2004 | 29 | 0.020 |
Why?
|
| Operating Rooms | 1 | 2011 | 817 | 0.020 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2005 | 130 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 1364 | 0.010 |
Why?
|
| Recurrence | 2 | 2006 | 8340 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1991 | 2015 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2017 | 5021 | 0.010 |
Why?
|
| Temperature | 1 | 2010 | 2206 | 0.010 |
Why?
|
| Ligation | 1 | 2004 | 453 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 1889 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2010 | 1130 | 0.010 |
Why?
|
| Phenotype | 2 | 2015 | 16365 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2007 | 12245 | 0.010 |
Why?
|
| Narcotics | 1 | 2005 | 343 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 2008 | 1206 | 0.010 |
Why?
|
| Surgical Wound Infection | 2 | 2004 | 1540 | 0.010 |
Why?
|
| Observer Variation | 1 | 2009 | 2593 | 0.010 |
Why?
|
| Pulmonary Veins | 1 | 2008 | 761 | 0.010 |
Why?
|
| Ebstein Anomaly | 1 | 2003 | 97 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2505 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 1534 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2013 | 2002 | 0.010 |
Why?
|
| Critical Illness | 1 | 2015 | 2670 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
| Hypolipidemic Agents | 1 | 2006 | 604 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2008 | 1486 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2006 | 1616 | 0.010 |
Why?
|
| Infant | 1 | 2003 | 35136 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8324 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 1677 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 2004 | 795 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8388 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 13033 | 0.010 |
Why?
|
| Inflammation | 1 | 1999 | 10638 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 6895 | 0.010 |
Why?
|
| Propofol | 1 | 2006 | 629 | 0.010 |
Why?
|
| Incidental Findings | 1 | 2004 | 689 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2006 | 1026 | 0.010 |
Why?
|
| Data Collection | 1 | 2009 | 3341 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2010 | 8436 | 0.010 |
Why?
|
| Base Sequence | 1 | 2010 | 12797 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 2004 | 816 | 0.010 |
Why?
|
| Incidence | 2 | 2008 | 20947 | 0.010 |
Why?
|
| Gene Expression | 1 | 2012 | 7799 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2005 | 1530 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 4420 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2003 | 1850 | 0.010 |
Why?
|
| Mediastinum | 1 | 1999 | 267 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 2006 | 1162 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2006 | 1364 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 3251 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10943 | 0.010 |
Why?
|
| Artifacts | 1 | 2006 | 1904 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 7785 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2006 | 3420 | 0.010 |
Why?
|
| Atrial Function, Left | 1 | 1997 | 173 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 4215 | 0.010 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1996 | 177 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2004 | 2240 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13815 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2282 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 19229 | 0.010 |
Why?
|
| Erythrocyte Transfusion | 1 | 1999 | 565 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2005 | 1213 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 1997 | 1105 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 24260 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 18111 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 21746 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2007 | 3679 | 0.010 |
Why?
|
| Adolescent | 2 | 2015 | 85781 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 29144 | 0.010 |
Why?
|
| Pneumonia | 1 | 2004 | 2133 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8642 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2005 | 5985 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1996 | 2031 | 0.010 |
Why?
|
| Algorithms | 1 | 2012 | 13881 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1991 | 666 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 81183 | 0.010 |
Why?
|
| Child | 2 | 2008 | 77709 | 0.000 |
Why?
|
| Cognition | 1 | 2004 | 6770 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1991 | 6622 | 0.000 |
Why?
|
| Burns | 1 | 1991 | 1815 | 0.000 |
Why?
|
| Mutation | 1 | 2004 | 29786 | 0.000 |
Why?
|